BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9129773)

  • 21. Update on insulin pump therapy.
    Marschilok C
    School Nurse News; 2007 Jan; 24(1):12-3. PubMed ID: 17283701
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraperitoneal insulin absorption after long-term intraperitoneal insulin therapy.
    Scavini M; Pincelli A; Petrella G; Galimberti G; Zager PG; Torri M; Pozza G
    Diabetes Care; 1995 Jan; 18(1):56-9. PubMed ID: 7698048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable insulin pumps: diagnosis and management of decreased flow rates using radionuclide investigation.
    Boulahdour H; Behar A; Haardt MJ; Selam JL
    Int J Artif Organs; 1996 Dec; 19(12):723-9. PubMed ID: 9029249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troubleshooting insulin self-administration.
    Karch AM; Karch FE
    Am J Nurs; 2000 Jul; 100(7):24. PubMed ID: 10914064
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Catheter occlusion during intraperitoneal infusion of insulin with implanted infusion devices].
    Schulz G; Beyer J; Hogan M
    Dtsch Med Wochenschr; 1985 Nov; 110(48):1852-5. PubMed ID: 3905331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant hyperkalemia after discontinuation of an insulin pump.
    Groudine SB; Phan B
    J Clin Anesth; 2005 Dec; 17(8):630-2. PubMed ID: 16427537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter survival during long-term insulin therapy with an implanted programmable pump. The Implantable Insulin Pump Trial Study Group.
    Scavini M; Galli L; Reich S; Eaton RP; Charles MA; Dunn FL
    Diabetes Care; 1997 Apr; 20(4):610-3. PubMed ID: 9096988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.
    Højbjerre L; Skov-Jensen C; Kaastrup P; Pedersen PE; Stallknecht B
    Diabetes Technol Ther; 2009 May; 11(5):301-6. PubMed ID: 19425878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Implantable insulin pump: surgical implantation under local anesthesia. (Technical note apropos of 35 cases)].
    Glock Y; Galinier P; Dalous P; Hanaire-Broutin H; Lacombe S; Lafon F; Tauber JP
    Ann Chir; 1992; 46(5):445-9. PubMed ID: 1416757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newest insulin delivery options.
    Johns Hopkins Med Lett Health After 50; 2001 Jul; 13(5):1-2, 7. PubMed ID: 14727583
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes.
    Vantyghem MC; Marcelli-Tourvieille S; Fermon C; Duhamel A; Raverdy V; Arnalsteen L; Kerr-Conte J; Noel C; Fontaine P; Pattou F
    Transplantation; 2009 Jan; 87(1):66-71. PubMed ID: 19136893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pumps and glucose regulation.
    Thompson JS; Duckworth WC
    World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
    Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
    Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.